Uthealth Houston
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1967-01-01
- Employees
- 11
- Market Cap
- -
Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2
Phase 2
Terminated
- Conditions
- Lung Diseases, Obstructive
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2008-01-08
- Target Recruit Count
- 44
- Registration Number
- NCT00135252
- Locations
- 🇺🇸
Memorial Hermann Children's Hospital, Houston, Texas, United States
Brief Intervention to Reduce Injury in Minorities
Not Applicable
Completed
- Conditions
- InjuriesAlcohol Related Disorders
- Interventions
- Behavioral: Brief intervention based on motivational interviewingBehavioral: Standard Care including referral for treatment
- First Posted Date
- 2005-08-19
- Last Posted Date
- 2013-01-30
- Target Recruit Count
- 1493
- Registration Number
- NCT00132262
Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants
Phase 3
Completed
- Conditions
- Gastroesophageal Reflux
- Interventions
- First Posted Date
- 2005-08-17
- Last Posted Date
- 2014-01-15
- Target Recruit Count
- 18
- Registration Number
- NCT00131248
- Locations
- 🇺🇸
Memorial Hermann Children's Hospital, Houston, Texas, United States
Atherosclerosis, Plaque and CVD in Communities
Completed
- Conditions
- Cerebrovascular AccidentCoronary ArteriosclerosisAtherosclerosisCardiovascular DiseasesHeart DiseasesCoronary Disease
- First Posted Date
- 2004-09-20
- Last Posted Date
- 2021-10-01
- Target Recruit Count
- 2000
- Registration Number
- NCT00091754
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
Phase 2
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2012-02-13
- Target Recruit Count
- 48
- Registration Number
- NCT00082862
- Locations
- 🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States
Modeling DNA Diversity in Reverse Cholesterol Transport
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesAtherosclerosis
- First Posted Date
- 2003-07-10
- Last Posted Date
- 2021-10-01
- Target Recruit Count
- 4146
- Registration Number
- NCT00064493
Gene-Environment Interactions in Complex Disease
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesCoronary DiseaseAtherosclerosis
- First Posted Date
- 2003-07-10
- Last Posted Date
- 2021-10-01
- Target Recruit Count
- 15792
- Registration Number
- NCT00064506
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
Phase 1
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2009-04-30
- Target Recruit Count
- 30
- Registration Number
- NCT00004063
- Locations
- 🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
Phase 2
- Conditions
- Breast CancerCervical CancerEndometrial CancerOvarian Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2009-04-30
- Target Recruit Count
- 34
- Registration Number
- NCT00003135
- Locations
- 🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States
Genetic Epidemiology of Change in CVD Risk Factors
Completed
- Conditions
- Cardiovascular DiseasesHeart Diseases
- Interventions
- Genetic: Polymorphisms measured
- First Posted Date
- 2002-05-17
- Last Posted Date
- 2014-12-03
- Target Recruit Count
- 1735
- Registration Number
- NCT00037440
© Copyright 2025. All Rights Reserved by MedPath